Better Context Better Decisions

Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.

$599
Posted in: Autologous, BCMA, CAR-T, CD19, CD22 Jul 03 | 2020Two New Gracell Early Ph1 Trials in MM and NHL PostedPurchase Blast
janssen cover image
$599
Posted in: SGLT2i Jul 02 | 2020CREDENCE Approved by ECPurchase Blast
tandem cover image
$599
Posted in: Insulin Delivery Jun 30 | 2020UnitedHealth to Cover Tandem PumpsPurchase Blast
biocorp cover image
$599
Posted in: Glucose Monitoring, Insulin Delivery Jun 30 | 2020Biocorp Partners with Roche in France for Mallya DistributionPurchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery Jun 29 | 2020Abbott/Tandem Finalize AID Partnership; What is Tandem’s Role?Purchase Blast
$599
Posted in: Glucose Monitoring Jun 25 | 2020Menarini Launches GlucoMen CGM in EuropePurchase Blast
$599
Posted in: Glucose Monitoring Jun 19 | 2020Libre 2 AID Compatibility HypothesisPurchase Blast
$599
Posted in: Allogeneic, Autologous, CAR-T, CD19, TCR Jun 19 | 2020Ziopharm Appoints Carl June as Chairman of Scientific Advisory BoardPurchase Blast
$599
Posted in: Insulin Delivery Jun 19 | 2020Roche Sues Insulet for Omnipod RoyaltiesPurchase Blast
1 2 3 42

Get the Latest Analysis

Stay informed and aligned with frequent updates to keep a pulse on the industry.

If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.